CN102210758A - Application of Chinese medicine composition in preparation of medicine for treating ankylosing spondylitis - Google Patents
Application of Chinese medicine composition in preparation of medicine for treating ankylosing spondylitis Download PDFInfo
- Publication number
- CN102210758A CN102210758A CN2010101411898A CN201010141189A CN102210758A CN 102210758 A CN102210758 A CN 102210758A CN 2010101411898 A CN2010101411898 A CN 2010101411898A CN 201010141189 A CN201010141189 A CN 201010141189A CN 102210758 A CN102210758 A CN 102210758A
- Authority
- CN
- China
- Prior art keywords
- water
- chinese medicine
- extract
- lignum
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses application of a Chinese medicine composition in preparation of a medicine for treating ankylosing spondylitis. The Chinese medicine composition disclosed by the invention comprises the following components of: ginseng, leech, chilopod, scorpion, ground beeltle, periostracum cicada, radix paeoniae rubra, borneol and the like, and has the curative effects of benefiting qi and activating blood circulation, and eliminating blood stasis and activating meridians. Proved by clinical experiments, the Chinese medicine composition disclosed by the invention can be used for effectively treating the ankylosing spondylitis.
Description
Technical field
The present invention relates to a kind of new purposes of Chinese medicine composition, particularly, the present invention relates to the application of a kind of Chinese medicine composition in preparation treatment ankylosing spondylitis medicine, belong to the Chinese medicine application.
Background technology
Ankylosing spondylitis (AS) is a kind of chronic general immune disease, is feature to invade sacroiliac joint and axis joint, also can involve eye, lung, kidney and other organs and cardiovascular system in various degree.Primary disease is more common in male adults, and sickness rate is about 3 ‰ in China.In early days show as the stiff or pain in back, rigid spine, deformity can take place in late period, cause severe dysfunction more, and disability rate is about 20%～30%, has a strong impact on patients ' life quality, bring heavy burden for society and family.
Chinese medicine thinks that ankylosing spondylitis is under the jurisdiction of categories such as " BI-syndrome involved the kidney ", " rheumatism involving the bone ", and the past traditional Chinese medical science early has abundant argumentation to ankylosing spondylitis." element is asked ": " sick at bone, the heavy erectile problem of bone, aching pain in the bone marrow, cold extremely, name is said rheumatism involving the bone ", " rheumatism involving the bone is endlessly felt in heresy interior the house in kidney again " reach " BI-syndrome involved the kidney person, kind bloated, inability to stand up straightly as if the function of heels is replaced by the sacral bone, hunchback "; Wang Bing says: " governor vessel is for sick, opisthotonos and can not bend and stretch also ".Modern medicine is not clear fully to its origin cause of formation, thereby also lacks the effectively preventing measure.Because ankylosing spondylitis is the chronic progressive external inflammatory diseases, be commonly encountered diseases, frequently-occurring disease, and not only touching difficulty is more, disability rate very high (remained shock reaches. the Chinese traditional treatment progress of ankylosing spondylitis. the 30th the 12nd phase of volume of Yunnan Chinese medicine magazine .2009).Still there is not specific short at present both at home and abroad, main Therapeutic Method has disease that calls for specialized treatment sick specially side, medicine administered by injection combination, operative treatment etc., the western medicine medicine includes NSAID (non-steroidal anti-inflammatory drug), sulfasalazine, methotrexate, glucocorticoid, biological preparation etc., so clinical treatment is very thorny.Motherland's medical science has the history in thousands of years, is accumulating rich experience aspect the treatment ankylosing spondylitis, thereby considerable status is arranged clinically.
The present invention is the improvement invention of carrying out on the basis of No. 01131203.3 and No. 200410048292.2 patent, quotes in full the content of this two patent documents record at this.The application of unexposed this Chinese medicine composition of above-mentioned two patents in the treatment ankylosing spondylitis.
Summary of the invention
The object of the invention provides the application of a kind of Chinese medicine composition in preparation treatment ankylosing spondylitis medicine, and described Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 3-10 Hirudo 3-11 Eupolyphaga Seu Steleophaga 5-10 Olibanum (system) 1-5 Radix Paeoniae Rubra 3-9 Lignum Dalbergiae Odoriferae 1-5
Lignum Santali Albi 1-5 Scorpio 3-9 Periostracum Cicadae 3-12 Scolopendra 1-3 Borneolum Syntheticum 1-7 Semen Ziziphi Spinosae (stir-fry) 3-10;
Preferably, this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 6 Hirudo 10 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 7 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5;
Or:
Radix Ginseng 10 Hirudo 8 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 9 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5;
Or:
Radix Ginseng 6 Hirudo 11 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 3 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5;
The active component of above-mentioned Chinese medicine composition is made up of following ingredients:
The a mean diameter is less than Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga, Periostracum Cicadae and the Olibanum (processed) medicated powder of 100 μ m;
B Borneolum Syntheticum medicated powder;
The volatile oil that c is extracted by Lignum Dalbergiae Odoriferae and Lignum Santali Albi;
The alcohol-extracted extract of the alcohol extract of d Radix Ginseng after after concentrating with ethanol extraction;
The water extracted immersing paste that is condensed into behind the water extract after the Lignum Dalbergiae Odoriferae behind the e extraction composition c and water extract, Radix Paeoniae Rubra and the Semen Ziziphi Spinosae (parched) of Lignum Santali Albi medicinal residues decoct with water and the water extract filtration of the medicine residues of Radix Ginseng after the extraction ingredient d, the mixing.
In the Chinese medicine composition of the present invention, as the latin name of the crude drug of active component and processing method thereof from " Chinese medicine voluminous dictionary " (in July, 1977, front page, Shanghai science tech publishing house) and " Chinese pharmacopoeia (version in 2005, Chemical Industry Press).
The invention also discloses that to contain above-mentioned Chinese medicine composition be capsule, tablet, granule, powder, oral liquid or pill as the pharmaceutical preparation of active component.
For above-mentioned dosage form can be realized, need when these dosage forms of preparation, to add the pharmacy acceptable auxiliary, for example: filler, disintegrating agent, lubricant, suspending agent, binding agent, sweeting agent, correctives, antiseptic, substrate etc.Filler comprises: starch, pregelatinized Starch, lactose, mannitol, chitin, microcrystalline Cellulose, sucrose etc.; Disintegrating agent comprises: starch, pregelatinized Starch, microcrystalline Cellulose, carboxymethyl starch sodium, crospolyvinylpyrrolidone, low-substituted hydroxypropyl cellulose, cross-linking sodium carboxymethyl cellulose etc.; Lubricant comprises: magnesium stearate, sodium lauryl sulphate, Pulvis Talci, silicon dioxide etc.; Suspending agent comprises: polyvinylpyrrolidone, microcrystalline Cellulose, sucrose, agar, hydroxypropyl emthylcellulose etc.; Binding agent comprises, starch slurry, polyvinylpyrrolidone, hydroxypropyl emthylcellulose etc.; Sweeting agent comprises: saccharin sodium, Aspartane, sucrose, cyclamate, enoxolone etc.; Correctives comprises: sweeting agent and various essence; Antiseptic comprises: parabens, benzoic acid, sodium benzoate, sorbic acid and its esters, benzalkonium bromide, fixed, the Folium eucalypti globueli (Eucalyptus globulus Labill.) wet goods of acetic acid chloroethene; Substrate comprises: PEG6000, PEG4000, insect wax etc.
Capsule of the present invention is preferably made by following preparation method: five kinds of Chinese medicine such as the Hirudo of said ratio, Scorpio, Periostracum Cicadae, Eupolyphaga Seu Steleophaga, Scolopendra cleaned, and oven drying at low temperature, standby; Lignum Santali Albi, Lignum Dalbergiae Odoriferae extract volatile oil, and medicinal residues and aqueous solution are standby; Radix Ginseng extracts secondary with 70% alcohol heating reflux, and 3 hours for the first time, 2 hours for the second time, merge extractive liquid, reclaimed ethanol to there not being the alcohol flavor; The medicinal residues of medicine residues of Radix Ginseng and Lignum Santali Albi, Lignum Dalbergiae Odoriferae merge with aqueous solution, add Radix Paeoniae Rubra, Semen Ziziphi Spinosae (stir-fry), decoct with water secondary, 3 hours for the first time, 2 hours for the second time, collecting decoction filters, and filtrate is concentrated into the clear paste that relative density is 1.20-1.25 (60 ℃), add above-mentioned panaxynol extract, mixing, cold drying is ground into fine powder; The five tastes such as Olibanum (system) and Hirudo are ground into fine powder altogether; The Borneolum Syntheticum porphyrize, with above-mentioned fine powder facing-up, mixing sprays into volatile oil respectively, and mixing incapsulates, promptly.
Perhaps, capsule of the present invention is preferably made by following preparation method:
A) weight ratio of crude drug is: Radix Ginseng 3-10 part, Hirudo 3-11 part, Eupolyphaga Seu Steleophaga 5-10 part, Olibanum (processed) 1-5 part, Radix Paeoniae Rubra 3-9 part, Lignum Dalbergiae Odoriferae 1-5 part, Lignum Santali Albi 1-5 part, Scorpio 3-9 part, Periostracum Cicadae 3-12 part, Scolopendra 1-3 part, Borneolum Syntheticum 1-7 part, Semen Ziziphi Spinosae (parched) 3-10 part;
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 100 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae decoct with water, after the water extract filters, extractum to be condensed into; Radix Ginseng with ethanol extraction after, reuse water extraction, alcohol extract are condensed into alcohol-extracted extract after reclaiming ethanol, the water extract filter with all water extract mixings after be condensed into the water extracted immersing paste;
D) preparation process:
In Fluidbedgranulatingdrier, add the superfine powder flour, again the step c) gained is extracted extractum and spray into granulation; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that extracts by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, by the capsule filler filling, make capsule behind the mixing.
Perhaps, capsule of the present invention is preferably made by following preparation method:
A) weight ratio of crude drug is: Radix Ginseng 3-10 part, Hirudo 3-11 part, Eupolyphaga Seu Steleophaga 5-10 part, Olibanum (system) 1-5 part, Radix Paeoniae Rubra 3-9 part, Lignum Dalbergiae Odoriferae 1-5 part, Lignum Santali Albi 1-5 part, Scorpio 3-9 part, Periostracum Cicadae 3-12 part, Scolopendra 1-3 part, Borneolum Syntheticum 1-7 part, Semen Ziziphi Spinosae (parched) 3-10 part;
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 100 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae decoct with water, after the water extract filters, extractum to be condensed into; Radix Ginseng with ethanol extraction after, reuse water extraction, alcohol extract are condensed into alcohol-extracted extract after reclaiming ethanol, the water extract filter with all water extract mixings after be condensed into the water extracted immersing paste, extractum directly is spray dried to spray powder;
D) preparation process:
The superfine powder flour is added in the Fluidbedgranulatingdrier with step c) gained spray drying powder, sprays solvent again and make granule; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that extracts by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, by the capsule filler filling, make capsule behind the mixing.
The consumption of pharmaceutical composition of the present invention is converted to the weight of raw medicinal material, is each 0.8-3 gram, and take 2-4 every day, is preferably each 1.11-2.22 and restrains, and takes every day three times.
The specific embodiment
Embodiment 1: the preparation of capsule
A) the crude drug prescription is:
Radix Ginseng 39.6g Hirudo 72.6g Eupolyphaga Seu Steleophaga 46.2g Olibanum (system) 13.2g
Radix Paeoniae Rubra 33g Lignum Dalbergiae Odoriferae 13.2g Lignum Santali Albi 13.2g Scorpio 19.8g
Periostracum Cicadae 46.2g Scolopendra 6.6g Borneolum Syntheticum 33g Semen Ziziphi Spinosae (stir-fry) 33g;
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 30-40 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae add suitable quantity of water and decoct secondary, and each 3 hours, merge the water extract, after the filtration, extractum to be condensed into; Radix Ginseng is with an amount of 70% ethanol extraction secondary, each 3 hours, merge extractive liquid,, reclaim ethanol to there not being the alcohol flavor, the reuse water extraction, alcohol extract is condensed into 60 ℃, and to measure relative densities be 0.9～1.1 alcohol-extracted extract, the water extract filter with above-mentioned all water extract mixings after be concentrated into 60 ℃ to measure relative densities be 0.9～1.1 clear paste, standby;
D) preparation process:
In Fluidbedgranulatingdrier, add the superfine powder flour, again the step c) gained is extracted extractum and spray into granulation; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that extracts by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, by the capsule filler filling, make 1000 capsules behind the mixing.
Amount of drug of the present invention for each 2-4 grain, is taken three times every day.
Embodiment 2: the preparation of tablet
A) the crude drug prescription is:
Radix Ginseng 66g Hirudo 52.8g Eupolyphaga Seu Steleophaga 46.2g Olibanum (system) 13.2g
Radix Paeoniae Rubra 33g Lignum Dalbergiae Odoriferae 13.2g Lignum Santali Albi 13.2g Scorpio 59.4g
Periostracum Cicadae 46.2g Scolopendra 6.6g Borneolum Syntheticum 33g Semen Ziziphi Spinosae (stir-fry) 33g
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 70-90 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae add suitable quantity of water and decoct secondary, and each 3 hours, merge the water extract, after the filtration, extractum to be condensed into; Radix Ginseng is with an amount of 70% ethanol extraction secondary, each 3 hours, merge extractive liquid,, reclaim ethanol to there not being the alcohol flavor, the reuse water extraction, alcohol extract is condensed into relative density and is determined as 1.0～1.05 alcohol-extracted extracts at 60 ℃, the water extract filter with above-mentioned all water extract mixings after be concentrated into 60 ℃ to measure relative densities be 1.0～1.1 clear paste, standby;
D) preparation process:
In Fluidbedgranulatingdrier, add the superfine powder flour, again the step c) gained is extracted extractum and spray into granulation; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that is extracted by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, preparation process is pressed into 1000 routinely.
Amount of drug of the present invention for each 2-4 sheet, is taken three times every day.
Embodiment 3: the preparation of pill
A) the crude drug prescription is:
Radix Ginseng 39.6g Hirudo 66g Eupolyphaga Seu Steleophaga 46.2g Olibanum (system) 13.2g
Radix Paeoniae Rubra 33g Lignum Dalbergiae Odoriferae 13.2g Lignum Santali Albi 13.2g Scorpio 46.2g
Periostracum Cicadae 46.2g Scolopendra 6.6g Borneolum Syntheticum 33g Semen Ziziphi Spinosae (stir-fry) 33g
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes medicated powder mean diameter 10-20 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae add suitable quantity of water and decoct secondary, and each 3 hours, merge the water extract, after the filtration, extractum to be condensed into; Radix Ginseng is with an amount of 70% ethanol extraction secondary, each 3 hours, merge extractive liquid,, reclaim ethanol to there not being the alcohol flavor, the reuse water extraction, alcohol extract is condensed into 60 ℃, and to measure relative densities be 0.9～1.0 alcohol-extracted extract, the water extract filter with above-mentioned all water extract mixings after be concentrated into 60 ℃ to measure relative densities be 1.0～1.1 clear paste, standby;
D) preparation process:
Preparation process is made 1000 pills routinely.
Amount of drug of the present invention for each 2-4 grain, is taken three times every day.
Experimental example:
For illustrating the activity of traditional Chinese medicine composition for treating ankylosing spondylitis of the present invention, use the capsule (to call medicine of the present invention in the following text) that makes by the foregoing description 1 method to carry out following test proving its curative effect, but it can not constitute any restriction to scope of the present invention.
1. data and method
1.1 physical data
All cases are selected between 2006.01-2009.01, and the Hebei Yi Ling hospital outpatient and the patients with ankylosing spondylitis of being in hospital be totally 81 examples, male 50 examples, women 31 examples, average 26.4 years old, the course of disease 4 months～31 years, average 12 years; 26 examples have repeatedly mistaken diagnosis, malpractice history.All case all has inflammation of sacroiliac joint and destruction.
All patients are divided into treatment group and matched group at random, treatment group case 41 examples, male 24 examples, women 17 examples; Matched group case 40 examples, male 26 examples, women 14 examples.
1.2 diagnostic criteria
Revised the New York standard according to 1984: 1. the lumbago waist is more than stiff March, and improve movable back, and the nothing of having a rest is improved; 2. lumbar vertebra limitation of activity all around; 3. thorax limitation of activity; 4. the X line has sacroiliitis to sexually revise.
1.3 Therapeutic Method
The treatment group is taken medicine of the present invention (being produced by Shijiazhuang Yiling Pharmaceutical Co., Ltd), every day 3 times, each 4.
Matched group is taken kidney tonifying and is exempted from spleen ball (being produced by Jiangsu ZhengDa QingJiang Pharmaceutical Co., Ltd), every day 3 times, each 8 grams.
8 weeks were a course of treatment, and two groups compare.
1.4 efficacy assessment standard
Produce effects: pain disappears, and function of joint is recovered substantially, life, working properly;
Effectively: pain obviously alleviates, and function of joint is limited slightly, and life, ability to work are improved;
Invalid: pain does not have and is clearly better, and function of joint does not have improvement
1.5 statistical method
All data are carried out statistical procedures with the SPSS14.0 statistical package, with one factor analysis of variance the significance of specimen mean differences are tested.
2 results
The clinical total effects comparison of table 1 (example, %)
Annotate: compare * P＜0.05 with matched group
Clinical total effects compares, and the matched group total effective rate is 75.0%, and treatment group total effective rate is 92.7%, and treatment group total effective rate and matched group compare, and P＜0.05 has significant difference.
3 conclusions
Confirm by above clinical trial, clinical drug treatment ankylosing spondylitis of the present invention, determined curative effect, and have no adverse reaction, therefore, medicine of the present invention can effectively be treated ankylosing spondylitis.
Claims (8)
1. the application of Chinese medicine composition in the preparation medicine, this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 3-10 Hirudo 3-11 Eupolyphaga Seu Steleophaga 5-10 Olibanum (system) 1-5 Radix Paeoniae Rubra 3-9 Lignum Dalbergiae Odoriferae 1-5
Lignum Santali Albi 1-5 Scorpio 3-9 Periostracum Cicadae 3-12 Scolopendra 1-3 Borneolum Syntheticum 1-7 Semen Ziziphi Spinosae (stir-fry) 3-10,
It is characterized in that the application of this Chinese medicine composition in preparation treatment ankylosing spondylitis medicine.
2. application as claimed in claim 1 is characterized in that, this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 6 Hirudo 10 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 7 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5.
3. application as claimed in claim 1 is characterized in that, this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 10 Hirudo 8 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 9 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5.
4. application as claimed in claim 1 is characterized in that, this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 6 Hirudo 11 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 3 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5.
5. as each described application among the claim 1-4, it is characterized in that the active component of described Chinese medicine composition is made up of following ingredients:
The a mean diameter is less than Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga, Periostracum Cicadae and Olibanum (system) medicated powder of 100 μ m;
B Borneolum Syntheticum medicated powder;
The volatile oil that c is extracted by Lignum Dalbergiae Odoriferae and Lignum Santali Albi;
The alcohol-extracted extract of the alcohol extract of d Radix Ginseng after after concentrating with ethanol extraction;
The water extracted immersing paste that is condensed into behind the water extract after the Lignum Dalbergiae Odoriferae behind the e extraction composition c and water extract, Radix Paeoniae Rubra and the Semen Ziziphi Spinosae (stir-fry) of Lignum Santali Albi medicinal residues decoct with water and the water extract filtration of the medicine residues of Radix Ginseng after the extraction ingredient d, the mixing.
6. as each described application among the claim 1-4, it is characterized in that the preparation formulation of this Chinese medicine composition is capsule, tablet, granule, powder, oral liquid or pill.
7. according to the preparation method of the described medicine capsule of claim 6, it is characterized in that it is made by following steps:
A) take by weighing each crude drug according to the weight portion ratio;
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 100 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae decoct with water, after the water extract filters, extractum to be condensed into; Radix Ginseng with ethanol extraction after, reuse water extraction, alcohol extract are condensed into alcohol-extracted extract after reclaiming ethanol, the water extract filter with all water extract mixings after be condensed into the water extracted immersing paste;
D) preparation process:
In Fluidbedgranulatingdrier, add the superfine powder flour, again the step c) gained is extracted extractum and spray into granulation; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that extracts by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, by the capsule filler filling, make capsule behind the mixing.
8. according to the preparation method of the described medicine capsule of claim 6, it is characterized in that it is made by following steps:
A) take by weighing each crude drug according to the weight portion ratio;
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 100 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae decoct with water, after the water extract filters, extractum to be condensed into; Radix Ginseng with ethanol extraction after, reuse water extraction, alcohol extract are condensed into alcohol-extracted extract after reclaiming ethanol, the water extract filter with all water extract mixings after be condensed into the water extracted immersing paste, extractum directly is spray dried to spray powder;
D) preparation process:
The superfine powder flour is added in the Fluidbedgranulatingdrier with step c) gained spray drying powder, sprays solvent again and make granule; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that extracts by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, by the capsule filler filling, make capsule behind the mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101411898A CN102210758A (en) | 2010-04-08 | 2010-04-08 | Application of Chinese medicine composition in preparation of medicine for treating ankylosing spondylitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101411898A CN102210758A (en) | 2010-04-08 | 2010-04-08 | Application of Chinese medicine composition in preparation of medicine for treating ankylosing spondylitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102210758A true CN102210758A (en) | 2011-10-12 |
Family
ID=44742442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101411898A Pending CN102210758A (en) | 2010-04-08 | 2010-04-08 | Application of Chinese medicine composition in preparation of medicine for treating ankylosing spondylitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102210758A (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008106821A1 (en) * | 2007-03-05 | 2008-09-12 | Hebei Yiling Medicine Research Institute Co., Ltd. | A chinese medicine composition and the extract of worms thereof and their preparation |
| CN101612215A (en) * | 2008-06-25 | 2009-12-30 | 河北以岭医药研究院有限公司 | The application of a kind of Chinese medicine composition in the medicine of preparation reduction drug resistance of nitric acid ester |
| CN101632726A (en) * | 2008-07-21 | 2010-01-27 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparing medicament for treating blood vessel micro-embolization |
| CN101632729A (en) * | 2008-07-25 | 2010-01-27 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparing medicament for treating involution syndrome |
| CN101632727A (en) * | 2008-07-21 | 2010-01-27 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparing medicament for treating pulmonary hypertension |
| CN101653487A (en) * | 2008-08-22 | 2010-02-24 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparation of medicament for treating acute cerebral infarction |
| CN101653489A (en) * | 2008-08-22 | 2010-02-24 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparation of medicament for preventing diabetes |
| CN101653488A (en) * | 2008-08-22 | 2010-02-24 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparation of medicament for resisting myocardial stunning |
| CN101683405A (en) * | 2008-09-23 | 2010-03-31 | 河北以岭医药研究院有限公司 | Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing brain stroke |
| CN101683406A (en) * | 2008-09-23 | 2010-03-31 | 河北以岭医药研究院有限公司 | Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing hypertension |
-
2010
- 2010-04-08 CN CN2010101411898A patent/CN102210758A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008106821A1 (en) * | 2007-03-05 | 2008-09-12 | Hebei Yiling Medicine Research Institute Co., Ltd. | A chinese medicine composition and the extract of worms thereof and their preparation |
| CN101612215A (en) * | 2008-06-25 | 2009-12-30 | 河北以岭医药研究院有限公司 | The application of a kind of Chinese medicine composition in the medicine of preparation reduction drug resistance of nitric acid ester |
| CN101632726A (en) * | 2008-07-21 | 2010-01-27 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparing medicament for treating blood vessel micro-embolization |
| CN101632727A (en) * | 2008-07-21 | 2010-01-27 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparing medicament for treating pulmonary hypertension |
| CN101632729A (en) * | 2008-07-25 | 2010-01-27 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparing medicament for treating involution syndrome |
| CN101653487A (en) * | 2008-08-22 | 2010-02-24 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparation of medicament for treating acute cerebral infarction |
| CN101653489A (en) * | 2008-08-22 | 2010-02-24 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparation of medicament for preventing diabetes |
| CN101653488A (en) * | 2008-08-22 | 2010-02-24 | 河北以岭医药研究院有限公司 | Application of Chinese medicinal composition in preparation of medicament for resisting myocardial stunning |
| CN101683405A (en) * | 2008-09-23 | 2010-03-31 | 河北以岭医药研究院有限公司 | Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing brain stroke |
| CN101683406A (en) * | 2008-09-23 | 2010-03-31 | 河北以岭医药研究院有限公司 | Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing hypertension |
Non-Patent Citations (1)
| Title |
|---|
| 樊冬香: "通心络治疗强直性脊柱炎48例临床研究", 《络病学基础与临床研究（5）》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101491572A (en) | Medicine for treating calculus and preparation method thereof | |
| CN1321671C (en) | Chinese medicinal composition, its preparation method and use | |
| CN101683405B (en) | Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing brain stroke | |
| CN101683406B (en) | Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing hypertension | |
| CN101632727B (en) | Application of Chinese medicinal composition in preparing medicament for treating pulmonary hypertension | |
| CN101744906B (en) | Applications of Chinese medicinal composition in preparation of medicament for treating facial paralysis | |
| CN101632729B (en) | Application of Chinese medicinal composition in preparing medicament for treating involution syndrome | |
| CN101632730B (en) | Application of Chinese medicinal composition in preparing medicament for treating affective disorder | |
| CN102210758A (en) | Application of Chinese medicine composition in preparation of medicine for treating ankylosing spondylitis | |
| CN101590122B (en) | Application of traditional Chinese medicine composition in preparing medicament for treating male infertility | |
| CN101269133A (en) | Application of Chinese medicinal composition in preparing medicament for treating facial spasm | |
| CN101632728B (en) | Application of Chinese medicinal composition in preparing medicament for protecting blood brain barrier | |
| CN102743456B (en) | The application of a kind of Chinese medicine composition in the medicine of preparation control delayed encephalopathy after acute carbon monoxide poisoning | |
| CN101439116B (en) | Use of Chinese medicinal composition in preparing medicament for treating diabetes mellitus induced erectile dysfunction | |
| CN101744905B (en) | Applications of Chinese medicinal composition in preparation of medicament for treating pulmonary heart disease | |
| CN102210760A (en) | Application of Chinese medicinal component in preparation of medicament for treating chronic epididymitis | |
| CN101612217B (en) | Application of Chinese medicinal composition in preparation of medicaments for treating central serous chorioretinopathy | |
| CN101757153B (en) | Application of traditional Chinese medicine composition in preparation of medicines for treating kidney deficiency blood stasis type erectile dysfunction | |
| CN112076276B (en) | Pharmaceutical composition for treating allergic rhinitis and preparation method thereof | |
| CN102210757B (en) | Application of Chinese medicine composition in preparation of medicine for treating coronary heart disease malignant arrhythmia | |
| CN101269142B (en) | Application of Chinese medicinal composition in preparing medicament for treating right bundle branch conduction block | |
| CN101590124A (en) | A kind of Chinese medicine composition improves application in the medicine of myocardial infarction prognosis in preparation | |
| CN101564438B (en) | Application of Chinese medicinal composition in preparation of medicament for treating acute severe brain injury | |
| CN101744917B (en) | Applications of Chinese medicinal composition to preparation of medicament for improving hypertension nervous symptoms | |
| CN101653487A (en) | Application of Chinese medicinal composition in preparation of medicament for treating acute cerebral infarction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20111012 |